MicroRNA-Driven Developmental Remodeling in the Brain Distinguishes Humans from Other Primates

Massey University, New Zealand
PLoS Biology (Impact Factor: 9.34). 12/2011; 9(12):e1001214. DOI: 10.1371/journal.pbio.1001214
Source: PubMed


While multiple studies have reported the accelerated evolution of brain gene expression in the human lineage, the mechanisms underlying such changes are unknown. Here, we address this issue from a developmental perspective, by analyzing mRNA and microRNA (miRNA) expression in two brain regions within macaques, chimpanzees, and humans throughout their lifespan. We find that constitutive gene expression divergence (species differences independent of age) is comparable between humans and chimpanzees. However, humans display a 3-5 times faster evolutionary rate in divergence of developmental patterns, compared to chimpanzees. Such accelerated evolution of human brain developmental patterns (i) cannot be explained by life-history changes among species, (ii) is twice as pronounced in the prefrontal cortex than the cerebellum, (iii) preferentially affects neuron-related genes, and (iv) unlike constitutive divergence does not depend on cis-regulatory changes, but might be driven by human-specific changes in expression of trans-acting regulators. We show that developmental profiles of miRNAs, as well as their target genes, show the fastest rates of human-specific evolutionary change, and using a combination of computational and experimental methods, we identify miR-92a, miR-454, and miR-320b as possible regulators of human-specific neural development. Our results suggest that different mechanisms underlie adaptive and neutral transcriptome divergence, and that changes in the expression of a few key regulators may have been a major driving force behind rapid evolution of the human brain.

Download full-text


Available from: Augix Guohua Xu,
  • Source
    • "We found differential expression of several microRNAs in the matched tissue comparison; however, this approach did not indicate how the expression levels relate to normal cortical tissue from non-TSC subjects. To address that question, we utilized microRNA data from a postmortem (PM) study of primate brain tissue that included samples from human, chimpanzee, and macaque (Somel et al. 2011). The study investigated microRNA expression in prefrontal cortex and cerebellar cortex from subjects representing a wide range of ages. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Tuberous sclerosis complex (TSC) is a multisystem genetic disorder caused by mutations in the TSC1 and TSC2 genes. Over 80% of TSC patients are affected by epilepsy, but the molecular events contributing to seizures in TSC are not well understood. Recent reports have demonstrated that the brain is enriched with microRNA activity, and they are critical in neural development and function. However, little is known about the role of microRNAs in TSC. Here, we report the characterization of aberrant microRNA activity in cortical tubers resected from 5 TSC patients surgically treated for medically intractable epilepsy. By comparing epileptogenic tubers with adjacent nontuber tissue, we identified a set of 4 coordinately overexpressed microRNAs (miRs 23a, 34a, 34b*, 532-5p). We used quantitative liquid chromatography-tandem mass spectrometry (LC-MS/MS) proteomic profiling to investigate the combined effect of the 4 microRNAs on target proteins. The proportion of repressed proteins among the predicted targets was significantly greater than in the overall proteome and was highly enriched for proteins involved in synaptic signal transmission. Among the combinatorial targets were TSC1, coding for the protein hamartin, and several epilepsy risk genes. We found decreased levels of hamartin in epileptogenic tubers and confirmed targeting of the TSC1 3' UTR by miRs-23a and 34a. © The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
    Cerebral Cortex 12/2014; DOI:10.1093/cercor/bhu276 · 8.67 Impact Factor
  • Source
    • "Brameier et al. (2011), found that only 40 percent of other primates miRNAs are identical with their human ortholog[5]. On the other hand, there is substantial evidence that miRNAs may have played an important role in the evolution of human brain through expression regulation of neuron specific coding genes[6], [7]. Gazave et al., performed comparative genomic hybridization in the four great apes species and suggested that CNVs are subject to different selective pressures in different lineages[8]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: MicroRNAs (miRNAs) and copy number variations (CNVs) represent two classes of newly discovered genomic elements that were shown to contribute to genome plasticity and evolution. Recent studies demonstrated that miRNAs and CNVs must have co-evolved and interacted in an attempt to maintain the balance of the dosage sensitive genes and at the same time increase the diversity of dosage non-sensitive genes, contributing to species evolution. It has been previously demonstrated that both the number of miRNAs that target genes found in CNV regions as well as the number of miRNA binding sites are significantly higher than those of genes found in non-CNV regions. These findings raise the possibility that miRNAs may have been created under evolutionary pressure, as a mechanism for increasing the tolerance to genome plasticity. In the current study, we aimed in exploring the differences of miRNAs-CNV functional interactions between human and seven others species. By performing in silico whole genome analysis in eight different species (human, chimpanzee, macaque, mouse, rat, chicken, dog and cow), we demonstrate that miRNAs targeting genes located within CNV regions in humans have special functional characteristics that provide an insight into the differences between humans and other species.
    PLoS ONE 12/2013; 8(12):e81204. DOI:10.1371/journal.pone.0081204 · 3.23 Impact Factor
  • Source
    • "Meaningful parallel variation may be most simple and direct to observe in proteins, but variation in regulatory regions is likely to be more plentiful and perhaps more important for understanding complex disease. This extends to variation in microRNAs, the role of which, so far, has only been hinted at (Hu et al. 2011; Somel et al. 2011). Perhaps the most promising and interesting future avenue along these lines, however, is in CNVs. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Because of their strong similarities to humans across physiologic, developmental, behavioral, immunologic, and genetic levels, nonhuman primates are essential models for a wide spectrum of biomedical research. But unlike other animal models, nonhuman primates possess substantial outbred genetic variation, reducing statistical power and potentially confounding interpretation of results in research studies. Although unknown genetic variation is a hindrance in studies that allocate animals randomly, taking genetic variation into account in study design affords an opportunity to transform the way that nonhuman primates are used in biomedical research. New understandings of how the function of individual genes in rhesus macaques mimics that seen in humans are greatly advancing the rhesus macaques utility as research models, but epistatic interaction, epigenetic regulatory mechanisms, and the intricacies of gene networks limit model development. We are now entering a new era of nonhuman primate research, brought on by the proliferation and rapid expansion of genomic data. Already the cost of a rhesus macaque genome is dwarfed by its purchase and husbandry costs, and complete genomic datasets will inevitably encompass each rhesus macaque used in biomedical research. Advancing this outcome is paramount. It represents an opportunity to transform the way animals are assigned and used in biomedical research and to develop new models of human disease. The genetic and genomic revolution brings with it a paradigm shift for nonhuman primates and new mandates on how nonhuman primates are used in biomedical research.
    ILAR journal / National Research Council, Institute of Laboratory Animal Resources 11/2013; 54(2):154-65. DOI:10.1093/ilar/ilt044 · 2.39 Impact Factor
Show more